-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Olema Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2019 to Q3 2025.
- Olema Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2025 was $3.66M, a 19.4% increase year-over-year.
- Olema Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2025 was $15.4M, a 16.6% increase year-over-year.
- Olema Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2024 was $12.8M, a 53.9% increase from 2023.
- Olema Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $8.31M, a 277% increase from 2022.
- Olema Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $2.2M, a 457% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)